Fig. 4From: Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysisForest plots of comorbidity and treatment in SLE-associated DAH. a Infection. b CTX treatment. c IVIG treatment. d Plasmapheresis. e Mechanical ventilation. SLE, systemic lupus erythematosus; DAH, diffuse alveolar hemorrhage; OR, odds ratios; CTX, cyclophosphamide; IVIG, intravenous immunoglobulinBack to article page